Last $1.14 USD
Change Today 0.00 / 0.00%
Volume 58.6K
IMSC On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

implant sciences corp (IMSC) Snapshot

Open
$1.17
Previous Close
$1.14
Day High
$1.17
Day Low
$1.14
52 Week High
08/5/13 - $1.23
52 Week Low
02/13/14 - $0.72
Market Cap
72.2M
Average Volume 10 Days
99.6K
EPS TTM
$-0.35
Shares Outstanding
63.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMPLANT SCIENCES CORP (IMSC)

Related News

No related news articles were found.

implant sciences corp (IMSC) Related Businessweek News

No Related Businessweek News Found

implant sciences corp (IMSC) Details

Implant Sciences Corporation, together with its subsidiaries, develops, manufactures, and sells sensors and systems for the security, safety, and defense industries primarily in the United States, India, France, Iraq, and China. Its products include Quantum Sniffer a QS-H150 portable explosives detector for the simultaneous detection of explosives particulates and vapors with or without physical contact and in real-time; and Quantum Sniffer QS-B220 benchtop explosives and narcotics detector for the detection and identification of various military, commercial, and improvised explosives, as well as narcotics. The company offers its products for use in aviation and transportation security, high threat facilities and infrastructure, military installations, customs and border protection, and mail and cargo screening. Implant Sciences Corporation markets and sells its products through direct sales and marketing staff, as well as through a network of independent and specialized sales representatives, and distributors. The company was founded in 1984 and is headquartered in Wilmington, Massachusetts.

65 Employees
Last Reported Date: 09/30/13
Founded in 1984

implant sciences corp (IMSC) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $400.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $220.0K
Chief Operating Officer and Director
Total Annual Compensation: $250.0K
Vice President of Technology
Total Annual Compensation: $190.0K
Vice President of Manufacturing Operations
Total Annual Compensation: $235.0K
Compensation as of Fiscal Year 2013.

implant sciences corp (IMSC) Key Developments

Implant Sciences Corp. Presents at NIBA New York Investment Conference, Jun-17-2014

Implant Sciences Corp. Presents at NIBA New York Investment Conference, Jun-17-2014 . Venue: The Roosevelt Hotel, 45 E. 45th Street, New York, New York, United States.

Implant Sciences Corp. Reports Un-Audited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014

Implant Sciences Corp. reported un-audited consolidated earnings results for the third quarter and nine months ended March 31, 2014. For the quarter, the company reported revenues of $2,708,000 as compared with $1,262,000 for the comparable prior year period. The increase in revenue is due primarily to: a 1,050.0% increase in the number of QS-B220 benchtop units sold in the three months ended March 31, 2014, due to increased shipments to Asia and Europe, for use in infrastructure protection and air cargo screening, which resulted in a 1,082.3% increase in QS-B220 revenues. Net loss was $4,939,000 as compared with a net loss of $5,339,000 for the comparable prior year period. The company reported loss from operations of $3,218,000 compared to $4,004,000 for the same period last year. Diluted net loss per share of $0.08 compared to $0.10 and adjusted LBITDA of $2,299,000 compared to $2,307,000 for the last year. The decrease in the net loss is primarily due to higher sales and gross margin and by a $1.0 million decrease in stock-based compensation recorded on the September 2012 officer and director option grants in the three months ended March 31, 2014, partially offset by increased operating expenses and increased interest expense. For the nine months, the company reported revenues of $7,023,000 as compared with $9,615,000 for the comparable prior year period. The decrease in revenue is due primarily to an 60.2% decrease in the number of QS-H150 handheld units sold in the nine months ended March 31, 2014. Net loss was $15,341,000 as compared with a net loss of $21,810,000 for the comparable prior year period. The company reported loss from operations of $10,351,000 compared to $17,904,000 for the same period last year. Diluted net loss per share of $0.26 compared to $0.47 and adjusted LBITDA of $6,897,000 compared to $5,020,000 for the last year. The decrease in the net loss is primarily due to a $10.0 million decrease in stock-based compensation recorded in the nine months ended March 31, 2014 on option grants to directors and officers in September 2012, offset partially by increased operating expenses and increased interest expense.

Implant Sciences Corp. to Report Q3, 2014 Results on May 15, 2014

Implant Sciences Corp. announced that they will report Q3, 2014 results at 9:05 PM, GMT Standard Time on May 15, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMSC:US $1.14 USD 0.00

IMSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMSC.
View Industry Companies
 

Industry Analysis

IMSC

Industry Average

Valuation IMSC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.5x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPLANT SCIENCES CORP, please visit www.implantsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.